Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9227956 | Substituted amide compounds | Etzer Darout, Robert Dullea, Julie Jia Li Hawkins, Allyn T. Londregan, Paula M. Loria +3 more | 2016-01-05 |
| 8609680 | 2,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives | Samit Kumar Bhattacharya, Kimberly O. Cameron, Dilinie Fernando, Daniel Wei-Shung Kung, Allyn T. Londregan +1 more | 2013-12-17 |
| 7321040 | Triazolo-pyridines as anti-inflammatory compounds | John Frederick Braganza, Michael A. Letavic | 2008-01-22 |
| 7259171 | Di and trifluoro-triazolo-pyridines anti-inflammatory compounds | Mark A. Dombroski, Michael A. Letavic | 2007-08-21 |
| 7056918 | Benzimidazole anti-inflammatory compounds | Mark A. Dombroski, Michael A. Letavic | 2006-06-06 |
| 7037923 | Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines | Mark A. Dombroski, Michael A. Letavic | 2006-05-02 |
| 7030242 | Selective inhibition of aggrecanase in osteoarthritis treatment | Mark C. Noe, Michael A. Letavic, Louis S. Chupak | 2006-04-18 |
| 7012143 | Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines | Mark A. Dombroski, Michael A. Letavic | 2006-03-14 |
| 7005523 | Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines | Mark A. Dombroski, Michael A. Letavic | 2006-02-28 |
| 6696464 | Triazolo-pyridines anti-inflammatory compounds | Michael A. Letavic, Mark A. Dombroski, Allen J. Duplantier, Ellen Laird | 2004-02-24 |
| 6664395 | Benzotriazoles anti-inflammatory compounds | Michael A. Letavic, Mark A. Dombroski, Ellen Laird | 2003-12-16 |
| 6599890 | Arylsulfonyl hydroxamic acid derivatives | Mark C. Noe, Michael A. Letavic, Louis S. Chupak | 2003-07-29 |
| 6329397 | Hydroxy pipecolate hydroxamic acid derivatives | Mark C. Noe, Michael A. Letavic, Louis S. Chupak | 2001-12-11 |
| 6303636 | Arylsulfonylamino hydroxamic acid derivatives | Ralph P. Robinson | 2001-10-16 |
| 6214870 | Dioxocyclopentyl hydroxamic acids | Ralph P. Robinson | 2001-04-10 |